Yestar Group’s US$200 Million Restructuring

Dechert has advised Yestar Healthcare Holdings Company Limited on the transaction.Yestar Healthcare Holdings Company Limited, a leading distributor and service provider of in vitro diagnostic products…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here